Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Professional Survey Report Forecast 2017 to 2022

July 2017 | 120 pages | ID: GE0B1D3CE4EEN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

This report studies Glucagon Like Peptide-1 (GLP-1) Agonists in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2017, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

Novo Nordisk
AstraZeneca
Eli Lilly
GSK
Sanofi
Bristol-Myers Squibb
Amylin
company 8
company 9

By types, the market can be split into

• Type 1
• Type 2
• Type 3

By Application, the market can be split into

Hospital
Pharmacy
Application 3

By Regions, this report covers (we can add the regions/countries as you want)

North America
China
Europe
Southeast Asia
Japan
India

Contents

1 INDUSTRY OVERVIEW OF GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS

1.1 Definition and Specifications of Glucagon Like Peptide-1 (GLP-1) Agonists
  1.1.1 Definition of Glucagon Like Peptide-1 (GLP-1) Agonists
  1.1.2 Specifications of Glucagon Like Peptide-1 (GLP-1) Agonists
1.2 Classification of Glucagon Like Peptide-1 (GLP-1) Agonists
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Applications of Glucagon Like Peptide-1 (GLP-1) Agonists
  1.3.2 Hospital
  1.3.3 Pharmacy
  1.3.4 Application
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
2.3 Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
2.4 Industry Chain Structure of Glucagon Like Peptide-1 (GLP-1) Agonists

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS

3.1 Capacity and Commercial Production Date of Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016

4 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS OVERALL MARKET OVERVIEW

4.1 2012-2017 Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity and Growth Rate Analysis
  4.2.2 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate Analysis
  4.3.2 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price
  4.4.2 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Analysis (Company Segment)

5 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS REGIONAL MARKET ANALYSIS

5.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis
  5.1.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
  5.1.2 North America 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Analysis
  5.1.4 North America 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Analysis
5.2 China Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis
  5.2.1 China Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
  5.2.2 China 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Analysis
  5.2.4 China 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Analysis
5.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis
  5.3.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
  5.3.2 Europe 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Analysis
  5.3.4 Europe 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Analysis
5.4 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis
  5.4.1 Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
  5.4.2 Southeast Asia 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Analysis
  5.4.4 Southeast Asia 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Analysis
5.5 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis
  5.5.1 Japan Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
  5.5.2 Japan 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Analysis
  5.5.4 Japan 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Analysis
5.6 India Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis
  5.6.1 India Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
  5.6.2 India 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Analysis
  5.6.4 India 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Market Share Analysis

6 GLOBAL 2012-2017 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type
6.2 Different Types of Glucagon Like Peptide-1 (GLP-1) Agonists Product Interview Price Analysis
6.3 Different Types of Glucagon Like Peptide-1 (GLP-1) Agonists Product Driving Factors Analysis
  6.3.1 General keyboard membrane of Glucagon Like Peptide-1 (GLP-1) Agonists Growth Driving Factor Analysis
  6.3.2 Transparent keyboard membrane of Glucagon Like Peptide-1 (GLP-1) Agonists Growth Driving Factor Analysis
  6.3.3 Simulation keyboard membrane of Glucagon Like Peptide-1 (GLP-1) Agonists Growth Driving Factor Analysis
  6.3.4 Colorful keyboard membrane of Glucagon Like Peptide-1 (GLP-1) Agonists Growth Driving Factor Analysis
  6.3.5 Other of Glucagon Like Peptide-1 (GLP-1) Agonists Growth Driving Factor Analysis

7 GLOBAL 2012-2017 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption by Application
7.2 Different Application of Glucagon Like Peptide-1 (GLP-1) Agonists Product Interview Price Analysis
7.3 Different Application of Glucagon Like Peptide-1 (GLP-1) Agonists Product Driving Factors Analysis
  7.3.1 Office Use of Glucagon Like Peptide-1 (GLP-1) Agonists Growth Driving Factor Analysis
  7.3.2 Personal Use of Glucagon Like Peptide-1 (GLP-1) Agonists Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS

8.1 Novo Nordisk
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Picture and Specifications
  8.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 AstraZeneca
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Picture and Specifications
  8.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Eli Lilly
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Picture and Specifications
  8.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 GSK
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Picture and Specifications
  8.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 Sanofi
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Picture and Specifications
  8.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 Bristol-Myers Squibb
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Picture and Specifications
  8.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Amylin
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Picture and Specifications
  8.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 company
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Picture and Specifications
  8.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 company
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Picture and Specifications
  8.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

...

9 DEVELOPMENT TREND OF ANALYSIS OF GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKET

9.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Trend Analysis
  9.1.1 Global 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Forecast
9.2 Glucagon Like Peptide-1 (GLP-1) Agonists Regional Market Trend
  9.2.1 North America 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast
  9.2.2 China 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast
  9.2.3 Europe 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast
  9.2.5 Japan 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast
  9.2.6 India 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Forecast
9.3 Glucagon Like Peptide-1 (GLP-1) Agonists Market Trend (Product Type)
9.4 Glucagon Like Peptide-1 (GLP-1) Agonists Market Trend (Application)

10 GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS MARKETING TYPE ANALYSIS

10.1 Glucagon Like Peptide-1 (GLP-1) Agonists Regional Marketing Type Analysis
10.2 Glucagon Like Peptide-1 (GLP-1) Agonists International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Glucagon Like Peptide-1 (GLP-1) Agonists by Regions
10.4 Glucagon Like Peptide-1 (GLP-1) Agonists Supply Chain Analysis

11 CONSUMERS ANALYSIS OF GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Product Specifications of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Classification of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Global Production Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type in 2016
Table Applications of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Global Consumption Volume Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Application in 2016
Figure Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Regions
Figure North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (2012-2022)
Figure China Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (2012-2022)
Figure Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (2012-2022)
Figure Southeast Asia Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (2012-2022)
Figure Japan Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (2012-2022)
Figure India Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (2012-2022)
Table Glucagon Like Peptide-1 (GLP-1) Agonists Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists in 2016
Figure Manufacturing Process Analysis of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure Industry Chain Structure of Glucagon Like Peptide-1 (GLP-1) Agonists
Table Capacity and Commercial Production Date of Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Glucagon Like Peptide-1 (GLP-1) Agonists Major Manufacturers in 2016
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Glucagon Like Peptide-1 (GLP-1) Agonists 2012-2017
Figure Global 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Volume) and Growth Rate
Figure Global 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Value) and Growth Rate
Table 2012-2017 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity and Growth Rate
Table 2016 Global Glucagon Like Peptide-1 (GLP-1) Agonists Capacity List (Company Segment)
Table 2012-2017 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Growth Rate
Table 2016 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales List (Company Segment)
Table 2012-2017 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price
Table 2016 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption of Glucagon Like Peptide-1 (GLP-1) Agonists 2012-2017
Figure North America 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price
Figure North America 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption of Glucagon Like Peptide-1 (GLP-1) Agonists 2012-2017
Figure China 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price
Figure China 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption of Glucagon Like Peptide-1 (GLP-1) Agonists 2012-2017
Figure Europe 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price
Figure Europe 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption of Glucagon Like Peptide-1 (GLP-1) Agonists 2012-2017
Figure Southeast Asia 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price
Figure Southeast Asia 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption of Glucagon Like Peptide-1 (GLP-1) Agonists 2012-2017
Figure Japan 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price
Figure Japan 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption of Glucagon Like Peptide-1 (GLP-1) Agonists 2012-2017
Figure India 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price
Figure India 2016 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share
Table Global 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type
Table Different Types Glucagon Like Peptide-1 (GLP-1) Agonists Product Interview Price
Table Global 2012-2017 Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application
Table Different Application Glucagon Like Peptide-1 (GLP-1) Agonists Product Interview Price
Table Novo Nordisk Basic Information List
Table Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Global Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Global Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Eli Lilly Glucagon Like Peptide-1 (GLP-1) Agonists Global Market Share (2012-2017)
Table GSK Basic Information List
Table GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GSK Glucagon Like Peptide-1 (GLP-1) Agonists Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Global Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Global Market Share (2012-2017)
Table Amylin Basic Information List
Table Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Global Market Share (2012-2017)
Table company 8 Basic Information List
Table company 8 Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 8 Glucagon Like Peptide-1 (GLP-1) Agonists Global Market Share (2012-2017)
Table company 9 Basic Information List
Table company 9 Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin (2012-2017)
Figure company 9 Glucagon Like Peptide-1 (GLP-1) Agonists Global Market Share (2012-2017)
Figure Global 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Volume) and Growth Rate Forecast
Figure Global 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (Value) and Growth Rate Forecast
Figure Global 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Price Forecast
Figure North America 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Volume and Growth Rate Forecast
Figure China 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Volume and Growth Rate Forecast
Figure Europe 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Volume and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Volume and Growth Rate Forecast
Figure Japan 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Volume and Growth Rate Forecast
Figure India 2017-2022 Glucagon Like Peptide-1 (GLP-1) Agonists Consumption Volume and Growth Rate Forecast
Table Global Sales Volume of Glucagon Like Peptide-1 (GLP-1) Agonists by Types 2017-2022
Table Global Consumption Volume of Glucagon Like Peptide-1 (GLP-1) Agonists by Applications 2017-2022
Table Traders or Distributors with Contact Information of Glucagon Like Peptide-1 (GLP-1) Agonists by Regions